Fol. Biol. 2004, 50, 7-14
https://doi.org/10.14712/fb2004050010007
Loss of Tumorigenicity of Murine Colon Carcinoma MC38/0 Cell Line after Transduction with a Retroviral Vector Carrying Murine IL-12 Genes
References
1. , S. (1996) Gene-modified tumor cells as cellular vaccine. Cancer Immunol. Immunother. 43, 163-173.
<https://doi.org/10.1007/s002620050318>
2. , J. (1996) Gene transfer for immunotherapy of cancer. Gene Ther. 11, 944-945.
3. , B. (2002) Introduction: current concepts in immunity to human cancer and therapeutic antitumor vaccines. Immunol. Rev. 188, 5-8.
<https://doi.org/10.1034/j.1600-065X.2002.18801.x>
4. , T. H., Griswold, D. P. Jr., Roberts, B. J., Peckham, J. C., Schabel, F. M. Jr. (1975) Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res. 35, 2434-2439.
5. , M. K., Renzetti, L. M., Magram, J., Stern, A. S., Adorini, L., Gubler, U., Presky, D. H. (1998) The interleukin-12/interleukin-12 receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16, 361-495.
<https://doi.org/10.1146/annurev.immunol.16.1.495>
6. , H., Pajtasz-Piasecka, E., Radzikowski, C. (1996) Interleukin-2 gene therapy potentiates the antitumor effect of cytostatic agent in mice with advanced transplantable tumors. Biotechnologia 4, 68-79.
7. , M., Bubeník, J., Mikyšková, R., Vonka, V., Šmahel, M., Žák, R., Šímová, J., Mendoza, L., Jandlová, T. (2002) Tumour-inhibitory and antimetastatic effects of IL-2 in mice carrying MHC class Itumours of HPV16 origin. Int. J. Oncol. 20, 643-646.
8. , H., Pajtasz-Piasecka, E., Radzikowski, C. (1999) Synergistic antitumour effects of chemoimmunotherapy with an oxazaphosphorine drug and interleukin-2-secreting cells in a mouse colon cancer model. Med. Oncol. 16, 267-278.
<https://doi.org/10.1007/BF02785873>
9. Kuśnierczyk, H., Pajtasz-Piasecka, E., Koten, J.-W., Bijleveld, C., Krawczyk, K., Den Otter, W. Further development of local IL-2 therapy of cancer: multiple versus single IL-2 treatment of transplanted murine colon carcinoma. Cancer Immunol. Immunother. (in press)
10. , H., Kashiwamura, S., Tsutsui, H., Yoshimoto, T., Nakanishi, K. (1998) Regulation of interferon-γ production by IL-12 and IL-18. Curr. Opin. Immunol. 10, 259-264.
<https://doi.org/10.1016/S0952-7915(98)80163-5>
11. , E., Glazman-Kuśnierczyk, H., Salwa, J., Konarski, L., Radzikowski, C. (1995) Growth inhibition of transplantable tumors in mice by mIL-2-secreting murine plasmocytoma cells used alone or in combination with a cytostatic agent. Arch. Immunol. Ther. Exp. 43, 281-292.
12. , E., Kuśnierczyk, H., Krawczyk, K., Piasecki, E.,. Elas, M., Radzikowski, C. (2001) The effects of peritumoral therapeutic vaccination with IL-2-secreting cells on growth of MC38 colon tumors, local NO production and sentinel lymph node cells activation. Adv. Exp. Med. Biol. 495, 385-388.
<https://doi.org/10.1007/978-1-4615-0685-0_56>
13. , U., Luster, A., Vark, N. M., Homann, D., Gaedicke, G., Reisfeld, R. Lode, H. (2001) IFN-γ-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapy. J. Immunol. 166, 6944-6951.
<https://doi.org/10.4049/jimmunol.166.11.6944>
14. , J., Pełczyńska, M., Nasulewicz, A., Radzikowski, C., Opolski, A. (2002) Influence of the route of experimental tumor cells transplantation on the localization of metastases. Baltic J. Lab. Anim. Sci. 12, 103-109.
